Schizophrenia Research Today is a free monthly online journal that collates and summarizes the latest research about Schizophrenia, including details on paranoia, symptoms, treatment, depression, medication.

Volume 2 (2005), Issue 5 (May)

1. Handedness in children of schizophrenic parents: data from three high-risk studies.
   Behav Genet, 35(3): 351-8. [Abstract] [Full-text]
2. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
   Am J Psychiatry, 162(5): 1013-6. [Abstract] [Full-text]
3. Evidence for onset of antipsychotic effects within the first 24 hours of treatment.
   Am J Psychiatry, 162(5): 939-46. [Abstract] [Full-text]
4. Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia.
   Am J Psychiatry, 162(5): 931-8. [Abstract] [Full-text]
5. The Danish National Schizophrenia Project: prospective, comparative longitudinal treatment study of first-episode psychosis.
   Br J Psychiatry, 186: 394-9. [Abstract] [Full-text]
6. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study.
   Br J Psychiatry, 186: 369-77. [Abstract] [Full-text]
7. "I can put the medicine in his soup, Doctor!".
   J Med Ethics, 31(5): 262-5. [Abstract] [Full-text]
8. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii.
   Psychopathology, 38(2): 87-90. [Abstract] [Full-text]
9. Early-stage visual processing and cortical amplification deficits in schizophrenia.
   Arch Gen Psychiatry, 62(5): 495-504. [Abstract] [Full-text]
10. Reduced parahippocampal connectivity produces schizophrenia-like memory deficits in simulated neural circuits with reduced parahippocampal connectivity.
    Arch Gen Psychiatry, 62(5): 485-93. [Abstract] [Full-text]
11. Obstetric complications in siblings of Japanese schizophrenics: data from the Maternal and Child Health Handbook.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 617-20. [Abstract] [Full-text]
12. Psychophysiological differences in schizophrenics with and without delusional misidentification syndromes: a P300 study.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 593-601. [Abstract] [Full-text]
13. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 587-91. [Abstract] [Full-text]
14. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 543-8. [Abstract] [Full-text]
15. Diabetes mellitus in patients with schizophrenia in Taiwan.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 523-7. [Abstract] [Full-text]
16. Cost analysis of treating schizophrenia with amisulpride: naturalistic mirror image study.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 517-22. [Abstract] [Full-text]
17. Functional clustering in EEG photic and auditory driving in schizophrenia.
    Int J Psychophysiol, 56(3): 249-59. [Abstract] [Full-text]
18. Brain electrical activity changes in treatment refractory schizophrenics after olanzapine treatment.
    Int J Psychophysiol, 56(3): 237-47. [Abstract] [Full-text]
19. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study.
    Synapse, 57(1): 47-55. [Abstract] [Full-text]
20. Working memory consolidation is abnormally slow in schizophrenia.
    J Abnorm Psychol, 114(2): 279-90. [Abstract] [Full-text]
21. Cognitive impairments and disordered speech in schizophrenia: thought disorder, disorganization, and communication failure perspectives.
    J Abnorm Psychol, 114(2): 269-78. [Abstract] [Full-text]
22. Mothers talk about their children with schizophrenia: a performance autoethnography.
    J Psychiatr Ment Health Nurs, 12(3): 333-40. [Abstract] [Full-text]
23. Interval-timing deficits in individuals at high risk for schizophrenia.
    Brain Cogn, 58(1): 109-18. [Abstract] [Full-text]
24. Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophrenia.
    Brain Cogn, 58(1): 94-108. [Abstract] [Full-text]
25. A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid.
    Clin Ther, 27(3): 320-6. [Abstract] [Full-text]
26. Subjective experiences on antipsychotic medications: synthesis and conclusions.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
27. Adolescence, schizophrenia and drug abuse: a window of vulnerability.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
28. Neuroleptic dysphoria: revisiting the concept 50 years later.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
29. Handedness in schizophrenia: a quantitative review of evidence.
    Acta Psychiatr Scand, 111(6): 410-9. [Abstract] [Full-text]
30. The dorsal raphe nucleus in schizophrenia: a post mortem study of 5-hydroxytryptamine neurones.
    Neuropathol Appl Neurobiol, 31(3): 258-69. [Abstract] [Full-text]
31. Mapping cortical thickness and gray matter concentration in first episode schizophrenia.
    Cereb Cortex, 15(6): 708-19. [Abstract] [Full-text]
32. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
    J Psychopharmacol, 19(3): 301-5. [Abstract] [Full-text]
33. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    J Psychopharmacol, 19(3): 277-85. [Abstract] [Full-text]
34. Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients.
    Schizophr Bull, 31(1): 175-82. [Abstract] [Full-text]
35. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study.
    Schizophr Bull, 31(1): 167-74. [Abstract] [Full-text]
36. Various bilateral olfactory deficits in male patients with schizophrenia.
    Schizophr Bull, 31(1): 155-65. [Abstract] [Full-text]
37. Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia.
    Schizophr Bull, 31(1): 139-53. [Abstract] [Full-text]
38. Cortical cholinergic transmission and cortical information processing in schizophrenia.
    Schizophr Bull, 31(1): 117-38. [Abstract] [Full-text]
39. Enhanced vividness of mental imagery as a trait marker of schizophrenia?
    Schizophr Bull, 31(1): 97-104. [Abstract] [Full-text]
40. Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance.
    Schizophr Bull, 31(1): 85-96. [Abstract] [Full-text]
41. The micro-module learning tests: work-sample assessments of responsiveness to skills training.
    Schizophr Bull, 31(1): 73-83. [Abstract] [Full-text]
42. Learning potential and the prediction of work skill acquisition in schizophrenia.
    Schizophr Bull, 31(1): 67-72. [Abstract] [Full-text]
43. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation.
    Schizophr Bull, 31(1): 55-66. [Abstract] [Full-text]
44. The schizophrenic experience: taken out of context?
    Schizophr Bull, 31(1): 43-53. [Abstract] [Full-text]
45. "Theory of mind" in schizophrenia: a review of the literature.
    Schizophr Bull, 31(1): 21-42. [Abstract] [Full-text]
46. A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.
    Schizophr Bull, 31(1): 5-19. [Abstract] [Full-text]
47. No evidence for interaction between 5-HT2A receptor and serotonin transporter genes in schizophrenia.
    Neurosci Res, 52(2): 195-9. [Abstract] [Full-text]
48. Dysfunction of the anterior hippocampus: the cause of fundamental schizophrenic symptoms?
    Med Hypotheses, 65(1): 55-60. [Abstract] [Full-text]
49. Family burden in long-term diseases: a comparative study in schizophrenia vs. physical disorders.
    Soc Sci Med, 61(2): 313-22. [Abstract] [Full-text]
50. Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members.
    Soc Sci Med, 61(2): 305-11. [Abstract] [Full-text]
51. Smoking behavior in persons with a schizophrenia-spectrum disorder: a qualitative investigation of the transtheoretical model.
    Soc Sci Med, 61(2): 293-303. [Abstract] [Full-text]
52. Memory retrieval in schizophrenia: evidence from part-list cuing.
    J Int Neuropsychol Soc, 11(3): 273-80. [Abstract] [Full-text]
53. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation.
    Psychiatry Clin Neurosci, 59(3): 354-7. [Abstract] [Full-text]
54. Gait disturbances in patients with schizophrenia and adaptation to treadmill walking.
    Psychiatry Clin Neurosci, 59(3): 303-10. [Abstract] [Full-text]
55. Obsessive-compulsive symptoms in schizophrenia: prevalance and clinical correlates.
    Psychiatry Clin Neurosci, 59(3): 291-5. [Abstract] [Full-text]
56. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non-diabetic Japanese patients with schizophrenia.
    Psychiatry Clin Neurosci, 59(3): 266-73. [Abstract] [Full-text]
57. Efficacy of 3-year psychiatric daycare treatment in patients with schizophrenia.
    Psychiatry Clin Neurosci, 59(3): 246-52. [Abstract] [Full-text]
58. A family approach to severe mental illness in post-war Kosovo.
    Psychiatry, 68(1): 17-27. [Abstract] [Full-text]
59. Parallels between aging and schizophrenia.
    Psychiatry, 68(1): 1-8. [Abstract] [Full-text]
60. Structural violence and schizophrenia.
    Soc Sci Med, 61(3): 721-30. [Abstract] [Full-text]
61. Caring for the seriously mentally ill in Thailand: Buddhist family caregiving.
    Arch Psychiatr Nurs, 19(2): 44-57. [Abstract] [Full-text]
62. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Pharmacopsychiatry, 38(3): 132-8. [Abstract] [Full-text]
63. Occupational abilities and performance scale--reliability-validity assessment factor analysis.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 417-24. [Abstract] [Full-text]
64. Person-related predictors of employment outcomes after participation in psychiatric vocational rehabilitation programmes--a systematic review.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 408-16. [Abstract] [Full-text]
65. Labeling--stereotype--discrimination. An investigation of the stigma process.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 391-5. [Abstract] [Full-text]
66. The impact of family experience on the duration of untreated psychosis (DUP) in Hong Kong.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 350-6. [Abstract] [Full-text]
67. Duration of untreated psychotic illness: the role of premorbid social support networks.
    Soc Psychiatry Psychiatr Epidemiol, 40(5): 345-9. [Abstract] [Full-text]
68. The neurodevelopmental model of schizophrenia: update 2005.
    Mol Psychiatry, 10(5): 434-49. [Abstract] [Full-text]
69. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families.
    Mol Psychiatry, 10(5): 486-99. [Abstract] [Full-text]
70. Hyperprolinemia is a risk factor for schizoaffective disorder.
    Mol Psychiatry, 10(5): 479-85. [Abstract] [Full-text]
71. Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor.
    Mol Psychiatry, 10(5): 470-8. [Abstract] [Full-text]
72. Quantitative analysis of group-specific brain tissue probability map for schizophrenic patients.
    Neuroimage, 26(2): 502-12. [Abstract] [Full-text]
73. Functional integration in schizophrenia: too little or too much? Preliminary results on fMRI data.
    Neuroimage, 26(2): 374-88. [Abstract] [Full-text]
74. Neural correlates of enhanced genetic risk for schizophrenia.
    Neuroscientist, 11(3): 238-49. [Abstract] [Full-text]
75. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Neurosci Lett, 382(1): 27-32. [Abstract] [Full-text]
76. Category content and structure in schizophrenia: an evaluation using the instantiation principle.
    Neuropsychology, 19(3): 371-80. [Abstract] [Full-text]
77. Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval.
    Eur J Hum Genet, 13(6): 763-71. [Abstract] [Full-text]
78. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism.
    Synapse, 57(2): 91-9. [Abstract] [Full-text]
79. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
    Neuroscience, 133(2): 453-61. [Abstract] [Full-text]
80. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
    Prostaglandins Leukot Essent Fatty Acids, 72(6): 393-402. [Abstract] [Full-text]
81. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss.
    Mol Psychiatry, 10(6): 581-8. [Abstract] [Full-text]
82. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia.
    Mol Psychiatry, 10(6): 589-97. [Abstract] [Full-text]
83. High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy.
    Med Hypotheses, 65(2): 243-52. [Abstract] [Full-text]
84. Gender differences in age at onset of schizophrenia.
    J Coll Physicians Surg Pak, 15(6): 345-8. [Abstract] [Full-text]
85. Poor antisaccade performance in schizophrenia: an inhibition deficit?
    Psychiatry Res, 135(1): 1-10. [Abstract] [Full-text]
86. Are there common mechanisms in sensation seeking and reality distortion in schizophrenia? A study using memory event-related potentials.
    Psychiatry Res, 135(1): 11-33. [Abstract] [Full-text]
87. Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies.
    Psychiatry Res, 135(1): 65-75. [Abstract] [Full-text]

© 2004-2010 Schizophrenia Research Today. All Rights Reserved.